Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline

• Main Authors: M. Colaci (Author), D. Giuggioli (Author), M. Sebastiani (Author), A. Manfredi (Author), F. Lumetti (Author), F. Luppi (Author), S. Cerri (Author), C. Ferri (Author)
• Format: Book
• Published: PAGEPress Publications, 2016-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in systemic sclerosis (SSc) patients, generally related to the presence of interstitial lung disease (ILD) and/or pulmonary arterial hypertension (PAH). However, in clinical practice abnormally low DLCO values...